Paul Ellison

Global Commercial and Clinical Supply Chain

New Providence, New Jersey, United States

About

I am a senior leader with over 25 years experience managing complex supply chains and leading both commercial and clinical supply chain teams for large, medium and small biopharma companies. I specialize in launching new products with experience in SOD generics, sterile injectables, neuroscience and oncology products. My journey in the pharmaceutical sector has honed my ability to lead cross-functional teams with a focus on innovation and customer satisfaction. My expertise also encompasses strategic forecasting and replenishment, underscored by a commitment to resolve conflicts and build strong professional relationships. Our team's dedication to excellence in commercial supply chain management has significantly contributed to our organizational goals.

Experience

  • Senior Director, Global Supply Chain at Karyopharm Therapeutics Inc.
    Mar 2025 - Present · 1 yr 4 mos

    Commercial and clinical supply chain supporting global markets.

  • Senior Director, Commercial Supply Chain at Bristol Myers Squibb
    Mar 2024 - Dec 2024 · 10 mos

  • Senior Director, Commercial / Clinical Supply Chain at Karuna Therapeutics
    Dec 2022 - Mar 2024 · 1 yr 4 mos

  • Director, Commercial Supply Chain, New Product Launch at Alvogen
    Mar 2021 - Nov 2022 · 1 yr 9 mos

  • Director, New Product Launch at Viatris at Viatris
    Nov 2020 - Mar 2021 · 5 mos

    • Accountable for new product launch planning and execution of ~20 generic SKU’s annually • Ensure future revenues and long-range volume forecasts are aligned with our manufacturing unit forecast for a portfolio of +275 SKUs to support capacity planning • Lead product change and life cycle management activities for portfolio with $500M revenue • Improved customer service level KPIs by 20% by reducing overall delivery lead times by 3 days • Reduced cost of goods for 25% of portfolio by 10% via a cost management program • Oversee a cross-functional team that reduced lot sizes by 25% and safety stock by 3 weeks, generating annual savings of $20M